OPN-6602 Currently Treating Patients in Phase 1 Clinical Trial SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--April 15, 2026-- Opna Bio, a clinical-s ...
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva,” the “Company” “we” or “us”), a late-stage pharmaceutical ...
Through the collaboration, Silicon Box will work with industry leaders to advance automotive-grade chiplet devices with advanced packaging.
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva," the "Company" "we" or "us"), a late-stage pharmaceutical company developing therapies ...
Shares end at the highest since March 2; Virgin Australia reaffirms guidance; Nufarm rises the most since 2023; UBS; Mesoblast rises on licensing deal. Follow live.
Wayve has raised $60M from AMD, Arm, and Qualcomm Ventures, extending its $1.2B Series D. Robotaxi pilots with Uber are ...
As the bulk sector navigates tariffs, costs, and regulatory shifts, NTTC’s 2026 Annual Conference aims to foster industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results